Skip to main content
OpenTrials

Clinical trial condition

Basal Ganglia Diseases

Explore clinical trials studying Basal Ganglia Diseases. Study availability and eligibility vary by location and protocol.

4,065 public trials 750 recruiting studies
Refine in advanced search Browse all conditions

Basal Ganglia Diseases trial results

Completed

Advance Care Planning and Care Coordination for People With Parkinson's Disease

NCT05954013

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Paracelsus Medical University Salzburg, Austria
  • Estonian Movement Disorders Society Tartu, Estonia
  • Philipps University Marburg Medical Center Marburg, Germany
  • University of Ioannina Ioannina, Greece
View Trial Details
Completed

Parkinson's Foundation Quality Improvement Initiative

NCT01629043

Conditions
Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +11 more
Locations
  • Barrow Neurological Institute - Muhammad Ali Parkinson Center Phoenix, Arizona, United States
  • Parkinson's Institute and Clinical Center Sunnyvale, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida Parkinson's Disease and Movement Disorders Center Gainesville, Florida, United States
View all 24 locations
View Trial Details
Completed

Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations

NCT03877510

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Xenoscience, Inc (102) Phoenix, Arizona, United States
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute (156) Phoenix, Arizona, United States
  • Clinical Trials, Inc (113) Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences (117) Little Rock, Arkansas, United States
View all 98 locations
View Trial Details
Completed

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

NCT01839396

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Muhammad Ali Parkinson Research Center and Movement Disorders Clinic Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Kaiser Permanente, Sacramento Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies

NCT04001517

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • University of California San Diego (UCSD) La Jolla, California, United States
  • Pacific Neuroscience Institute Santa Monica, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Elite Clinical Research Miami, Florida, United States
View all 24 locations
View Trial Details

Related conditions